ArticlePharmaceutics2022

The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs.

André Schreiber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.